| Document |
Document Title |
|
WO/2023/167325A1 |
The present invention addresses the problem of developing a metal catalyst which is suitable for continuous flow organic synthesis reaction, is excellent in durability, and has high activity. The present invention provides an immobiliz...
|
|
WO/2023/159824A1 |
The present invention discloses a linear BODIPY electron donor having a 180º coordination included angle and a supramolecular metal macro-ring, and synthesis processes therefor and the use thereof. The present invention provides the lin...
|
|
WO/2023/155688A1 |
Disclosed is an oral Pt (IV) anti-cancer prodrug axially containing 3-bromopyruvic acid ligand, with the chemical name of cis,trans,cis-[Pt (1R,2R-diaminocyclohexane)(OH)(3-bromopyruvate)(C2O4)], which is a prodrug of oxaliplatin that is...
|
|
WO/2023/158183A1 |
The present invention relates to a platinum organometallic compound, a method for manufacturing same, a method for manufacturing a thin film using same, and a method for manufacturing a high-performance optical sensor for detecting mid-i...
|
|
WO/2023/156802A1 |
Our invention relates to catalysts and their use in the synthesis and conversion of alpha-olefin-containing products, essentially alpha-olefins, primarily from paraffins of renewable origin, having a carbon number of 11-45, and mixtures ...
|
|
WO/2023/156972A1 |
Disclosed herein are embodiments of a chiral Pd(0) precatalyst according to Formula I, wherein the Pd atom has an oxidation state of 0 and the A group is a compound comprising at least one olefin moiety capable of coordinating with Pd(0)...
|
|
WO/2023/154404A1 |
Some embodiments relate to precursors (including intermediate precursors) and related methods. To prepare an intermediate precursor, a mixture of bis (arene) metal complexes is combined with a first arene. The mixture of bis (arene) meta...
|
|
WO/2023/151513A1 |
The invention provides novel conjugates of tissue-binding small molecules and therapeutic agents and pharmaceutical compositions thereof, and their use in and methods of treatment of certain diseases or conditions (e.g., cancer).
|
|
WO/2023/149735A1 |
The invention relates to an organic molecule with a structure of L2MX, wherein M is Iridium; L and X are bidentate ligands; and wherein L is a TADF material.
|
|
WO/2023/142725A1 |
The present invention provides a cyclopropane skeleton monophosphine ligand and a palladium complex thereof as well as a preparation method and the use thereof. Specifically, the cyclopropane skeleton monophosphine ligand having a trans-...
|
|
WO/2023/143622A1 |
Disclosed in the present invention are a platinum compound with a non-Karstedt configuration, and a preparation method therefor and the use thereof. Provided in the present invention is a platinum compound with a non-Karstedt configurati...
|
|
WO/2023/146975A1 |
Disclosed are compounds of Formula (I), pharmaceutically acceptable salts thereof, and methods of preparation thereof, wherein R1, Xa, Xb, Xc, and Xd are as described in the specification. Further disclosed is an isotopic mixture of a co...
|
|
WO/2023/137518A1 |
The present disclosure relates to platinum complexes, and in particular platinum(II) and platinum(IV) complexes. The present disclosure also relates to synthesis of the platinum complexes, and to intermediates for the synthesis of the pl...
|
|
WO/2023/136252A1 |
Provided is an iridium complex compound represented by formula (1'). In the formula: R2 through R5 are selected from [substituent group W]; R1, R6 through R10, and R14 are a hydrogen atom, F, a methyl group, a trifluoromethyl group, an e...
|
|
WO/2023/134696A1 |
The present application provides a compound, an organic light emitting device and an electronic device. The compound has a structure shown in formula (1), wherein M represents Pd(II) or Pt(II). The compound helps to enable an organic lig...
|
|
WO/2023/134011A1 |
Provided in the present disclosure are a binuclear Schiff base cobalt complex, and a preparation method therefor and the use thereof. The binuclear Schiff base cobalt complex has a structure as shown in formula (I). In formula (I), R1 an...
|
|
WO/2023/134120A1 |
Disclosed in the present invention are a bipyridine ligand and amphiphilic rhombic supramolecular metal ring containing aggregation-induced emission (AIE) and aggregation-caused quenching (ACQ) groups and an application. A bipyridine lig...
|
|
WO/2023/136259A1 |
This platinum-phosphite complex-containing hydrosilylation catalyst is liquid at 23°C, does not contain a hydrocarbon-based organic solvent, and comprises: a platinum-phosphite complex formed of platinum and a phosphite compound having ...
|
|
WO/2023/132318A1 |
This optical film comprises a transparent substrate and a colored layer laminated on at least one surface of the transparent substrate. The colored layer contains a pigment (A); the pigment (A) contains a coloring material having a maxim...
|
|
WO/2023/116540A1 |
Disclosed are a pyridine pyrrole ruthenium complex, and a preparation method therefor and an application thereof as a catalyst for preparing hydrazine by electrocatalytic ammonia oxidation. In the pyridine pyrrole ruthenium complex, high...
|
|
WO/2023/116587A1 |
A binuclear platinum complex luminescent material having the structure of chemical formula (I), applied to an organic light-emitting diode and having good luminous efficiency and long device life. Also provided is an organic electrolumin...
|
|
WO/2023/120315A1 |
The present disclosure provides an organic metal complex characterized by being a compound represented by any one of general formulae (1) to (3). In general formulae (1) to (3), R1 and R2 are independently selected from the group consi...
|
|
WO/2023/114458A2 |
In one aspect, methods for the facile synthesis of cationic cobalt complexes for asymmetric hydrogenation of alkenes are provided. Synthetic methods described herein, in some embodiments, provide Co(I) precatalysts on a time scale and yi...
|
|
WO/2023/109722A1 |
A platinum complex light-emitting material based on carbazole modification and an application thereof. A platinum complex is a compound having a structure as represented by chemical formula I. An aza-condensed ring contained in this seri...
|
|
WO/2023/111478A1 |
The present invention relates to a silicone composition X which is cross-linkable by polyaddition reactions to form a silicone elastomer. In particular, the present invention relates to a silicone composition X which is cross-linkable by...
|
|
WO/2023/110784A1 |
The present invention relates to a compound of Formula I, Li(ox)]2[M1mM2nM3k(OH)pFq; wherein M1, M2 and M3 are metals; and X is a halogen chosen from F, Cl and Br; and m, n and k are, independently, a number between 0 and 5, the sum of m...
|
|
WO/2023/102063A1 |
Platinum group metal containing chemical precursors suitable for vapor deposition are disclosed. Methods of using these precursors for Platinum depositions are also disclosed. The chemical precursors and methods are particularly suitable...
|
|
WO/2023/100615A1 |
The present disclosure provides general formula (1). In general formulae (1) and (2), R1 to R21 are independently selected from a hydrogen atom and a substituent. CY1 is a group represented by one of chemical formulae 3-1 to 3-3. In ch...
|
|
WO/2023/099863A1 |
The invention relates to a process for the manufacture of (trimethyl)platinum iodide by the reaction between potassium hexachloroplatinate (K2PtCl6) and methyllithium (MeLi) followed by quenching with iodine (I2).
|
|
WO/2023/092612A1 |
Provided is a two-dimensional coordination polymer based on isocyano coordination and coordinated by carbon atoms and transition metal ions. The types of existing two-dimensional coordination polymers are expanded, and the possibility is...
|
|
WO/2023/093701A1 |
Provided are a platinum (II) compound having a targeting effect and a derivative thereof, a preparation method, a pharmaceutical composition, and the use. The platinum (II) compound has the following structure. The derivative of the plat...
|
|
WO/2023/093311A1 |
The present invention relates to a luminescent material made of a platinum complex having an NNCN tetradentate ligand, and an application thereof. The platinum complex has a structure of chemical formula (I). When applied to an organic l...
|
|
WO/2023/088919A1 |
The present invention relates to an iminium salt having the following formula (I) and also to a ruthenium complex having the following formula (II): (I) (II) as well as the use of said ruthenium complex as catalyst, in particular in olef...
|
|
WO/2023/090179A1 |
Provided is a thin film-forming material, for use in atomic layer deposition, that contains a ruthenium compound represented by general formula (1). (In the formula: R1 represents a hydrogen atom or a methyl group; and R2 and R3 indepe...
|
|
WO/2023/087843A1 |
Disclosed in the present invention are a neutral iridium complex containing nitrogen-sulfur four-membered ring coordination, and a preparation method therefor and an application thereof in preparation of an organic electronic device, par...
|
|
WO/2023/088620A1 |
The present invention relates to a phosphine of the formula (1), wherein - Q is SiR3R4, GeR3R4, SnR3R4, AsR3 or Se; - m is 0, 1, 2 or 3; n is 0, 1, 2 or 3; under the proviso that m + n ≥ 1; - the groups R independently of each other re...
|
|
WO/2023/082898A1 |
The present invention relates to a divalent platinum complex having high color purity, comprising a structure of chemical formula (I). The compound is applied to an organic light-emitting diode, has relatively low driving voltage and rel...
|
|
WO/2023/082896A1 |
The present invention relates to a high-efficiency divalent platinum complex phosphorescent OLED material and the use thereof, and a platinum complex containing an ONCN tetradentate ligand and the use thereof in an organic light-emitting...
|
|
WO/2023/085123A1 |
The present disclosure provides an organic light-emitting element that is provided with a positive electrode, a light-emitting layer, and a negative electrode in the stated order. The light-emitting layer contains a dopant material and a...
|
|
WO/2023/082897A1 |
The present invention relates to a metal iridium complex and to an application thereof. The metal iridium compound has the general formula Ir(La)(Lb)(Lc), wherein La is the structure shown in formula (1), and Lb is the structure shown in...
|
|
WO/2023/071147A1 |
The present invention relates to the technical field of electronic materials, and specifically relates to a binuclear metal platinum complex and an organic electroluminescent device. The binuclear metal platinum complex provided by the p...
|
|
WO/2023/070761A1 |
Provided in the present invention is an iridium-based catalyst, which is characterized in that the chemical structural formula thereof is as shown in (I), wherein Ph is a phenyl, R is a methyl or ethyl, and X is one or more of CH3CO2, NO...
|
|
WO/2023/071719A1 |
The present invention relates to a platinum complex luminescent material and a use thereof. The platinum complex is a compound having the structure represented by chemical formula (I), the compound can be applied in organic light-emittin...
|
|
WO/2023/075192A1 |
The present invention relates to a chromium-based organic/inorganic hybrid nanoporous body including a fluorine-bearing organic ligand and a nitro- or amine-bearing organic ligand, a manufacturing method therefore, and a use thereof.
|
|
WO/2023/065614A1 |
The present invention relates to an organic metal complex, a mixture, a composition, an organic electronic component, an electronic device, and an application. The structure of the metal complex provided in the present invention comprise...
|
|
WO/2023/064664A1 |
Aqueous anticaking agent solutions are prepared by mixing a ferrous source, a citrate source, a hydroxide source and water together. The ferrous source and the citrate source are present in a Fe to citrate molar ratio of from 0.5 to 1.5 ...
|
|
WO/2023/061999A1 |
The present invention discloses a distinct mode of action of a nickel catalyst to forge C-0 bonds to unlock the mild utilization of N2O as O-atom transfer reagent in the synthesis of complex phenols from the corresponding aryl halides.
|
|
WO/2023/063112A1 |
The present disclosure provides an organic compound represented by general formula [1]. In formula [1], R1 and R2 are each independently selected from a hydrogen atom, an alkyl group, or the like. R3 are each independently selected from ...
|
|
WO/2023/057982A1 |
The present disclosure generally relates to the synthesis of an alkoxylated cannabinoid using a double metal cyanide (DMC) catalyst. This procedure affords a novel process for preparing water-dispersible and water-soluble versions of can...
|
|
WO/2023/056898A1 |
A cobalt-containing acidic amino acid complex and its use for treating cancer. In some embodiments, the cobalt-containing complex is represented by Formula I or II.
|
